Name | brimonidine |
Synonyms | UBC UK 14 CS-1362 UK 14,34 uk 14,304 Brimonidine brimonidine Polyubiquitin-C UK 14304, Brimonidine 5-bromo-n-(4,5-dihydro-1h-imidazol-2-yl)-6-quinoxalinamin 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine 6-Quinoxalinamine,5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)- |
CAS | 59803-98-4 |
EINECS | 000-000-0 |
InChI | InChI=1/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17) |
Molecular Formula | C11H10BrN5 |
Molar Mass | 292.13 |
Density | 1.82±0.1 g/cm3(Predicted) |
Melting Point | 207.5 °C |
Boling Point | 432.6±55.0 °C(Predicted) |
Flash Point | 215.4°C |
Solubility | 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: <0.8mg/mL |
Vapor Presure | 1.1E-07mmHg at 25°C |
Merck | 14,1375 |
pKa | 7.69±0.10(Predicted) |
Storage Condition | Keep in dark place,Sealed in dry,2-8°C |
Refractive Index | 1.798 |
Hazard Symbols | T - Toxic |
Risk Codes | R25 - Toxic if swallowed R36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
UN IDs | UN 2811 6.1/PG 3 |
WGK Germany | - |
RTECS | VD1200000 |
HS Code | 29332900 |
Hazard Class | 6.1 |
Packing Group | Ⅲ |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.423 ml | 17.116 ml | 34.231 ml |
5 mM | 0.685 ml | 3.423 ml | 6.846 ml |
10 mM | 0.342 ml | 1.712 ml | 3.423 ml |
5 mM | 0.068 ml | 0.342 ml | 0.685 ml |